Clinical trial
EvaluAtion of Resynchronization Therapy for Heart Failure (EARTH)
NCT00900549 is registered in ClinicalTrials.gov with Montreal Heart Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EvaluAtion of Resynchronization Therapy for Heart Failure (EARTH)
- Lead sponsor
- Montreal Heart Institute
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- October 31, 2003
- Completion date
- July 31, 2011
- Enrollment
- 120 (estimated)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.